Human embryonic stem cell models of Huntington disease

Area of Science:

• Neuroscience
• Genetics
• Stem Cell Biology

Background:

• Huntington disease (HD) is a fatal neurodegenerative disorder linked to CAG repeat expansion in the HTT gene.
• Current in-vitro models for HD are limited, hindering research into disease mechanisms and therapeutic development.

Purpose of the Study:

• To establish and characterize human embryonic stem cell (hESC) lines modeling Huntington disease (HD).
• To assess the potential of these HD hESC lines as in-vitro tools for understanding neurodegeneration and for drug screening.

Main Methods:

• Derivation of hESC lines from embryos with confirmed Huntington disease (HD) genotypes (CAG(37) and CAG(51)) using preimplantation genetic diagnosis (PGD).
• Confirmation of HD genotypes via fluorescence polymerase chain reaction (F-PCR) and Genescan analysis.
• Analysis of mutant transcript and protein expression using RT-PCR and Western blotting.
• Induction of neural differentiation into neurospheres and subsequently neurons and astrocytes using noggin.
• Assessment of CAG repeat instability in differentiated cells using small pool PCR.

Main Results:

• Successfully derived and confirmed two HD hESC lines with partial and full penetrant mutant alleles.
• Demonstrated expression of mutant huntingtin transcripts and proteins in the HD hESC lines.
• Induced neural differentiation into neurospheres, neurons, and astrocytes.
• Observed instability of expanded CAG repeats during neural differentiation in vitro.
• Confirmed the presence of active HTT genes and neural differentiation potential.

Conclusions:

• The developed HD hESC lines provide a valuable human in-vitro model for studying Huntington disease.
• These models exhibit key disease features, including CAG repeat instability, making them suitable for investigating neurodegeneration mechanisms.
• The HD hESC lines offer a platform for screening potential therapeutic compounds for Huntington disease clinical trials.